Aizhan Tastanova

7PUBLICATIONS
62CO-AUTHORS
BiomaterialsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2025
Human Dermal Microvascular Arterial and Venous Blood Endothelial Cells and Their Use in Bioengineered Dermo-Epidermal Skin Substitutes.

Dominic Rütsche, Monica Nanni, Phil Cheng

|Aug 29, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma.

Florentia Dimitriou, Phil F Cheng, Annalisa Saltari

|Jun 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.

Mauro Esposito, Laura Yerly, Prachi Shukla

|Aug 10, 2023
Dynamic thresholding and tissue dissociation optimization for CITE-seq identifies differential surface protein abundance in metastatic melanoma.

Ulrike Lischetti, Aizhan Tastanova, Franziska Singer

|Mar 22, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.

Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler

|Oct 28, 2022
Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq.

Gaetana Restivo, Aizhan Tastanova, Zsolt Balázs

Pageof 2

Frequent Collaborators

4 joint publications

Mitchell P Levesque

3 joint publications

Federica Sella

3 joint publications

Phil F Cheng

2 joint publications

Michael Krauthammer